Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: ANTIBODIES AGAINST OX-40 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: Antiproliferative compounds and conjugates made therefrom Filling date: 6 Sep 2025 Issue date: 22 Dec 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: ISOFURANONE COMPOUNDS USEFUL AS HPK1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 |
Grant | Utility: Heterocyclic compounds useful as modulators of TNF alpha Filling date: 6 Sep 2025 Issue date: 15 Dec 2020 |
Application | Utility: 6-AZAINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Dec 2020 |
Grant | Utility: Carbohydrate content of CTLA4 molecules Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Azole amides and amines as alpha v integrin inhibitors Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Substituted bicyclic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: BSL2v2c2-Ig POLYPEPTIDES Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: [1,2,4]TRIAZOLO[4,3-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Nov 2020 |
Grant | Utility: Nucleic acids encoding an anti-CD40 antibody Filling date: 6 Sep 2025 Issue date: 24 Nov 2020 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Acyl sulfonamide NaV1.7 inhibitors Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Application | Utility: ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Spiroheptane salicylamides and related compounds as inhibitors of ROCK Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Thienopyridines and benzothiophenes useful as IRAK4 inhibitors Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Application | Utility: AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Grant | Utility: Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation Filling date: 6 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: SUBSTITUTED NITROGEN CONTAINING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: AMINO INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: Monocyclic heteroaryl substituted compounds Filling date: 6 Sep 2025 Issue date: 27 Oct 2020 |
Application | Utility: AMIDE SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Oct 2020 |
Grant | Utility: Compositions and methods for producing a composition Filling date: 6 Sep 2025 Issue date: 20 Oct 2020 |
Application | Utility: ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR Filling date: 6 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: BIARYL KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A HETEROBIARYL MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: CYCLOHEXYL ACID ISOXAZOLE AZOLES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: CYCLOHEXYL ACID ISOXAZOLE AZINES AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: ISOXAZOLE O-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A PYRIDINE OR PYRAZINE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: DIAZAINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: ISOXAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: PYRAZOLE O-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 1 Oct 2020 |
Grant | Utility: Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Spiro-fused cyclic ureas as inhibitors of rock Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Fibronectin type III domain proteins with enhanced solubility Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Application | Utility: PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: PYRROLIDINE GPR40 MODULATORS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: A METHOD TO MONITOR PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO ADMINISTRATION OF GLUCOCORTICOIDS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS Filling date: 6 Sep 2025 Issue date: 24 Sep 2020 |
Showing 400 to 450 of 772 patents.